Laurion Capital Management LP Emergent Bio Solutions Inc. Transaction History

Laurion Capital Management LP

  • $5.23 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$1.86 - $6.98 $35,901 - $134,727
19,302 New
19,302 $131,000
Q4 2019

Feb 13, 2020
SELL
$51.21 - $59.06 $368,712 - $425,232
-7,200 Closed
0 $0
Q3 2019

Nov 13, 2019
BUY
$40.6 - $57.2 $292,320 - $411,840
7,200 New
7,200 $376,000

Others Institutions Holding EBS

# of Institutions
172
Shares Held
36.8M
Call Options Held
336K
Put Options Held
203K
View Full List

About Emergent BioSolutions Inc.

EBS Quotes by TradingView
  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $384M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email